ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print May 14, 2008
Eur Respir J 2008, doi:10.1183/09031936.00008408
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mascaux, C.
Right arrow Articles by Sculier, J-P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mascaux, C.
Right arrow Articles by Sculier, J-P.


ORIGINAL ARTICLE

The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma

C. Mascaux 1*, F. Bex 2, B. Martin 3, A. Burny 4, A. Haller 5, M. Paesmans 6, K. Willard-Gallo 7, V. Ninane 8, J-P. Sculier 3

1 Dept of Intensive Care and Thoracic Oncology; and Research Fellow FNRS (National Fund of Scientific Research)
2 Institute for Microbiological Research J-M Wiame and Laboratory of Microbiology
3 Dept of Intensive Care and Thoracic Oncology
4 Laboratory of Molecular and Cellular Biology, Faculté Universitaire des Sciences Agronomiques de Gembloux (FUSAGx)
5 Dept of Pathology
6 Data Center (Biostatistician), Institut Jules Bordet
7 Laboratory of Molecular Immunology and; and Scientific Collaborator of the FNRS-Télévie, ULB (Université Libre de Bruxelles), Brussels, Belgium
8 Dept of Pneumology, CHU Saint-Pierre

* To whom correspondence should be addressed. E-mail: celine.mascaux{at}bordet.be.


   Abstract

MDM2 (Murine Double Minute, clone 2), p14arf (alternate reading frame), NPM (nucleophosmin) regulate p53 activity.

Two hundred biopsies, including normal bronchial, pre-invasive and invasive tissues, were examined for changes in NPM, p14arf, MDM2 and p53 expression patterns by immunohistochemistry and immunofluorescence with confocal microscopy.

NPM and p14arf displayed a diffuse nuclear staining in most normal bronchial tissue. The fraction of biopsies displaying higher MDM2 staining or a nucleolar relocalization of NPM increased at mild and moderate dysplasia, respectively. Two different modifications occurred in p14arf expression, its loss or its nucleolar relocalization, both increasing at severe dysplasia and both being associated with high MDM2 expression. In addition, the nucleolar relocalization of p14arf was associated with that of NPM. Immunofluorescence staining indicated that NPM and p14arf either colocalized in the nucleoplasm or in the nucleoli, before and from severe dysplasia, respectively. MDM2 was never detected in the nucleoli.

Changes occur thus in MDM2, p14arf and NPM level of expression and/or cellular distribution during early steps of lung carcinogenesis. Their relative localization by immunofluorescence supports the hypothesis that p14arf nucleolar relocalization impairs p14arf-MDM2 complexes formation and that NPM might sequester p14arf. But the demonstration of this hypothesis requires further functional studies.

Keywords:  Carcinogenesis, lung cancer, MDM2, nucleophosmin, p14arf







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the European Respiratory Society.